| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.1 | 0.6 |